Point mutations in the genes of Lipoprotein lipase, hepatic lipase, and insulin receptor as possible susceptibility alleles in familial combined hyperlipidemia

被引：0
|
作者：
Jaross, W [1 ]
Gehrisch, S [1 ]
Julius, U [1 ]
Kostka, H [1 ]
Hanefeld, HM [1 ]
机构：
[1] TECH UNIV DRESDEN,INST KLIN CHEM,D-8027 DRESDEN,GERMANY
来源：
ATHEROSCLEROSIS | 1997年 / 134卷 / 1-2期
关键词：
D O I：
10.1016/S0021-9150(97)88223-8
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：25 / 26
页数：2
相关论文
共 48 条
  • [31] The hepatic lipase gene locus is linked to LDL particle size and HDL-cholesterol levels in familial combined hyperlipidemia
    Allayee, H
    Dominguez, KM
    Aouizerat, BE
    Krauss, RM
    Rotter, JI
    Lu, JY
    Cantor, RM
    de Bruin, TWA
    Lusis, AJ
    CIRCULATION, 1999, 100 (18) : 255 - 255
  • [32] MOLECULAR-BASIS OF FAMILIAL CHYLOMICRONEMIA - MUTATIONS IN THE LIPOPROTEIN-LIPASE AND APOLIPOPROTEIN-C-II GENES
    REINA, M
    BRUNZELL, JD
    DEEB, SS
    JOURNAL OF LIPID RESEARCH, 1992, 33 (12) : 1823 - 1832
  • [33] Common variants in the lipoprotein lipase gene, but not those in the insulin receptor substrate-1, the β3-adrenergic receptor, and the intestinal fatty acid binding protein-2 genes, influence the lipid phenotypic expression in familial combined hyperlipidemia
    Campagna, F
    Montali, A
    Baroni, MG
    Maria, AT
    Ricci, G
    Antonini, R
    Verna, R
    Arca, M
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2002, 51 (10): : 1298 - 1305
  • [34] A FREQUENTLY OCCURRING MUTATION IN THE LIPOPROTEIN-LIPASE GENE (ASN291SER) CONTRIBUTES TO THE EXPRESSION OF FAMILIAL COMBINED HYPERLIPIDEMIA
    REYMER, PWA
    GROENEMEYER, BE
    GAGNE, E
    MIAO, L
    APPELMAN, EEG
    SEIDEL, JC
    KROMHOUT, D
    BIJVOET, SM
    VANDEOEVER, K
    BRUIN, T
    HAYDEN, MR
    KASTELEIN, JJP
    HUMAN MOLECULAR GENETICS, 1995, 4 (09) : 1543 - 1549
  • [35] A non-integrated iPSC line (SDQLCHi042-A) from a boy suffering from familial combined hyperlipidemia with compound heterozygous mutations of lipoprotein lipase gene
    Li, Zilong
    Zhang, Xue
    Li, Xiaomei
    Yang, Yanan
    Xin, Hongmei
    Yang, Xiaomeng
    Liu, Ning
    Gai, Zhongtao
    Liu, Yi
    STEM CELL RESEARCH, 2021, 53
  • [36] G-250A substitution in promoter of hepatic lipase gene is associated with dyslipidemia and insulin resistance in healthy control subjects and in members of families with familial combined hyperlipidemia
    Pihlajamäki, J
    Karjalainen, L
    Karhapää, P
    Vauhkonen, I
    Taskinen, MR
    Deeb, SS
    Laakso, M
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2000, 20 (07) : 1789 - 1795
  • [37] RXRγ gene variant is associated with lower HDL, lower lipoprotein lipase, advanced coronary artery disease, and more frequent in familial combined hyperlipidemia
    Nohara, A
    Tsuchida, M
    Katsuda, S
    Kawashiri, MA
    Higashikata, T
    Inazu, A
    Kobayashi, J
    Shimizu, M
    Mabuchi, H
    CIRCULATION, 2005, 112 (17) : U72 - U72
  • [38] A mutation in the promoter of the lipoprotein lipase (LPL) gene in a patient with familial combined hyperlipidemia and low LPL activity (vol 92, pg 4462, 1995)
    Yang, WS
    Nevin, DN
    Peng, RL
    Brunzell, JD
    Deeb, SS
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (01) : 524 - 524
  • [39] Interactions among the glucocorticoid receptor, lipoprotein lipase, and adrenergic receptor genes and plasma insulin and lipid levels in the Quebec family study
    Ukkola, O
    Pérusse, L
    Weisnagel, SJ
    Bergeron, J
    Després, JP
    Rao, DC
    Bouchard, C
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2001, 50 (02): : 246 - 252
  • [40] The V73M mutation in the hepatic lipase gene is associated with elevated cholesterol levels in four Dutch pedigrees with familial combined hyperlipidemia
    Hoffer, MJV
    Snieder, H
    Bredie, SJH
    Demacker, PNM
    Kastelein, JJP
    Frants, RR
    Stalenhoef, AFH
    ATHEROSCLEROSIS, 2000, 151 (02) : 443 - 450
12345